Isotopia Molecular Imaging · raw details

Radioactive Isotopes for Nuclear Therapy · Petah Tikva · Founded 2007

active Mature ← back to profile

Highlights

1 patentProfile claimed by owner

About

Radioactive Isotopes for Nuclear Therapy

Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes diagnostic and therapeutic radioactive isotopes and advanced PET and SPECT radiotracers.

Its flagship product, the radioisotope Lutetium-177 (both C.A and N.C.A), has attracted considerable attention and exhibited great promise in treating a variety of late-stage cancers, including metastatic prostate cancer and neuroendocrine tumors.

Its production facilities include an advanced nuclear pharmacy that provides radionuclide labelled compounds for PET/SPECT imaging, a cyclotron facility, and an aseptic manufacturing plant that also offers contract manufacturing services (CMO).

Identity

NameIsotopia Molecular Imaging
Slugisotopia
Type / kindstartup
Crunchbase IDisotopia-molecular-imaging
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP-bt88IDA

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityPetah Tikva
HQ addressAlexander Yanai Street 39, Petah Tikva, Israel

Web & social

Websitehttps://isotopia-global.com/
Careers pagehttps://isotopia-global.com/careers
LinkedInhttps://www.linkedin.com/company/7228777
Twitter / Xhttps://twitter.com/Isotopia_il
Facebookhttps://www.facebook.com/Isotopia.Molecular.Imaging
YouTubehttps://www.youtube.com/channel/UC0AuXqBUI4KHM-Opk8sq7Eg

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Simulation & ImagingBiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareLife SciencesPharmaceuticalsMedical Devices IndustryMedical Equipment
Business models
B2B
Tags
precision-medicinecancer-therapycancertargeted-cancer-therapyradiologyscanningradiopharmaceuticalshospitalspharma-companiesdoctorshealthcare-providerscancer-diagnosticscancer-researchpharmaceuticalsclinical-trialsbioconvergence

Funding

Total raised$3.8M
Current stageMature

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}